Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
August 2012 Vol 5, No 5, Special Issue ASCO 2012 Payers' Perspective
Renal-Cell Carcinoma
First-Line Treatments for Metastatic Renal-Cell Carcinoma Are Evolving
Read More
Renal-Cell Carcinoma
Tivozanib Outperforms Sorafenib as First-Line Treatment in Advanced Renal-Cell Carcinoma
Read More
Prostate Cancer
In Head-to-Head Comparison, Continuous Beats Intermittent Hormonal Therapy for Metastatic Prostate Cancer
Wayne Kuznar
Read More
Breast Cancer
Chemotherapy-Related Toxicity Adds to Economic Burden in Metastatic Breast Cancer
Caroline Helwick
Read More
Prostate Cancer
A Promising New Gene Test to Differentiate Between Aggressive and Indolent Disease
Wayne Kuznar
Read More
Multiple Myeloma
Pomalidomide Shows Strong Activity in Relapsed/Refractory Myeloma
Caroline Helwick
Read More
Prostate Cancer
Agent that Targets Heat Shock Protein Shows Activity in Castration-Resistant Prostate Cancer
Wayne Kuznar
Read More
Multiple Myeloma
First Oral Proteasome Inhibitor Active in Myeloma
Read More
Prostate Cancer
Abiraterone Before Chemotherapy a Successful Strategy in Prostate Cancer
Wayne Kuznar
Read More
Molecular Profiling Guiding Cancer Therapy
Caroline Helwick
Read More
1
2
3
4
Page 1 of 4
Results 1 - 10 of 33